IRIS
PICCOLO, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.926
EU - Europa 3.193
NA - Nord America 2.947
SA - Sud America 683
AF - Africa 146
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.905
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.779
SG - Singapore 2.775
RU - Federazione Russa 1.703
CN - Cina 1.087
BR - Brasile 562
IT - Italia 492
HK - Hong Kong 472
VN - Vietnam 292
NL - Olanda 282
DE - Germania 192
CA - Canada 89
FI - Finlandia 86
GB - Regno Unito 86
KR - Corea 72
IE - Irlanda 61
IN - India 54
MX - Messico 51
AR - Argentina 47
FR - Francia 47
CI - Costa d'Avorio 45
AT - Austria 38
SE - Svezia 38
BE - Belgio 33
ZA - Sudafrica 33
PL - Polonia 29
EC - Ecuador 26
BD - Bangladesh 24
ID - Indonesia 19
JP - Giappone 19
ES - Italia 18
UA - Ucraina 18
KE - Kenya 14
MA - Marocco 14
PY - Paraguay 14
IQ - Iraq 13
PK - Pakistan 13
TR - Turchia 12
PE - Perù 10
CH - Svizzera 9
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
JO - Giordania 8
UZ - Uzbekistan 8
CO - Colombia 7
LT - Lituania 7
CL - Cile 6
IL - Israele 6
PT - Portogallo 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AU - Australia 5
EG - Egitto 5
DO - Repubblica Dominicana 4
HU - Ungheria 4
KG - Kirghizistan 4
OM - Oman 4
PA - Panama 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
MD - Moldavia 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
PH - Filippine 3
PS - Palestinian Territory 3
RO - Romania 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AO - Angola 2
BF - Burkina Faso 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
CV - Capo Verde 2
CW - ???statistics.table.value.countryCode.CW??? 2
DM - Dominica 2
EE - Estonia 2
ET - Etiopia 2
GN - Guinea 2
GT - Guatemala 2
ME - Montenegro 2
MK - Macedonia 2
NE - Niger 2
NP - Nepal 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TJ - Tagikistan 2
YE - Yemen 2
AM - Armenia 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
Totale 11.874
Salva come PNG Salva come JPEG
Città #
Singapore 1.328
Hong Kong 470
Moscow 403
Hefei 346
Ashburn 307
Chandler 283
Amsterdam 252
Beijing 241
Naples 183
Santa Clara 140
Ho Chi Minh City 116
Millbury 114
Los Angeles 104
Nanjing 103
Boston 79
Redondo Beach 73
Des Moines 70
Munich 68
Seoul 68
New York 64
Princeton 64
Hanoi 59
Buffalo 55
Lawrence 50
Ottawa 50
The Dalles 47
São Paulo 44
Dallas 37
Wilmington 31
Courcelles 28
Nuremberg 28
Seattle 28
Mexico City 27
Denver 25
Frankfurt am Main 25
Milan 24
Napoli 24
Chicago 22
Warsaw 22
Brooklyn 21
Hebei 21
Lappeenranta 19
London 19
Orem 19
Poplar 18
Shenyang 18
Tokyo 18
Council Bluffs 17
Rio de Janeiro 17
Rome 17
Jiaxing 15
Montreal 15
Tianjin 15
Vienna 15
Haiphong 14
Johannesburg 14
Nanchang 14
Stockholm 14
Turku 14
Belo Horizonte 13
Brasília 13
Houston 13
Nairobi 13
Changsha 12
Chennai 12
Helsinki 12
Kronberg 12
Phoenix 12
Afragola 11
Atlanta 11
Guayaquil 11
San Giuseppe Vesuviano 11
Bengaluru 10
Da Nang 10
Toronto 10
Biên Hòa 9
Columbus 9
Jacksonville 9
San Francisco 9
Amman 8
Baku 8
Buenos Aires 8
Düsseldorf 8
Kunming 8
Lima 8
Mumbai 8
Norwalk 8
San Jose 8
Tashkent 8
Campinas 7
Manchester 7
Portsmouth 7
Torre del Greco 7
Asunción 6
Bern 6
Boardman 6
Dhaka 6
Falkenstein 6
Guangzhou 6
Newark 6
Totale 6.208
Salva come PNG Salva come JPEG
Nome #
1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention 199
A cross-sectional study evaluating hospitalization rates for chronic limb-threatening ischemia during the COVID-19 outbreak in Campania, Italy 141
Coronary stenting early before non-cardiac surgery: is the endothelial progenitor cell capturing coronary stent a solution? 124
Application of the 2016 ASE-EACVI Criteria for the Assessment of Diastolic Function in Arterial Hypertension 123
ADDED Index or percentage diameter of residual coronary stenosis to risk-stratify patients presenting with STEMI 116
Carotid plaque offsets sex-related differences in cardiovascular risk of young hypertensive patients 112
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry 112
Predictors of adherence to composite therapy after acute coronary syndromes 111
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial 110
Title The GPIIIA PIA2 Polymorphism is Associated with an Increased Risk of Cardiovascular Adverse Event 110
Sex-Related Differences in Left Ventricular Geometry Patterns in Patients With Arterial Hypertension 109
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention 108
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale : The FABOLUS FASTER Trial 107
Extent of cardiac damage and mortality in patients undergoing transcatheter aortic valve implantation 107
Incidence, predictors, and prognostic impact of temporary left bundle branch block after transcatheter aortic valve replacement 105
A new approach to percutaneous coronary revascularization in patients requiring undeferrable non-cardiac surgery 103
A New Approach to Percutaneous Coronary Revascularization in Patients Requiring Undeferrable Non Cardiac Surgery. 102
Echocardiographic Evaluation of Aortic Stenosis: A Comprehensive Review 101
Hemodynamic Performance of Transcatheter Aortic Valves: A Comprehensive Review 99
Impact of COVID-19 pandemic on timing and early clinical outcomes of transcatheter aortic valve implantation 98
Angiographic improvement in STEMI reperfusion: a single centre experience 98
Management of high and intermediate-high risk pulmonary embolism: A position paper of the Interventional Cardiology Working Group of the Italian Society of Cardiology 97
Is There Still a Role for Invasive Assessment of Aortic Gradient? 97
Myocardial mass affects diagnostic performance of non-hyperemic pressure-derived indexes in the assessment of coronary stenosis 97
Mortality reduction with transradial approach in patients with ST-segment elevation myocardial infarction: is the randomized evidence conclusive? 97
Echocardiographic Evaluation after Transcatheter Aortic Valve Implantation: A Comprehensive Review 96
Prolonged Time-to-antihypertensive Therapy Worsens Organ Damage and Blood Pressure Control in Arterial Hypertension 94
Changes and prognostic impact of noninvasive myocardial work indices in patients undergoing transcatheter aortic valve implantation 94
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 94
Coronary angioplasty with stenting for acute coronary syndrome in patients with isolated single coronary artery: a report of two cases 94
Adenosine-induced torsade de pointes complicating a fractional flow reserve measurement in a right coronary artery intermediate stenosis. 94
Exploring the physiologic variations and related determinants of left ventricular diastolic function among 381 healthy Caucasian adults by the 2016 American Society of Echocardiography-European Association of Cardiovascular Imaging guidelines 93
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 93
Coronary stenting early before non-cardiac surgery: is the endothelial progenitor cell capturing coronary stent a solution? 93
Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis. 93
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis. 93
Evidence Supporting Criteria for Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Intervention 92
Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials. 92
Pharmacotherapeutic Considerations for the Use of Prasugrel and Ticagrelor to Reduce Stent Thrombosis in Patients With Acute Coronary Syndrome. 92
Management of Intraventricular Gradient in Patients With Aortic Stenosis 91
Everolimus- versus first generation drug-eluting stents: the never-ending story of searching for a winner in the "limus family". 91
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions 90
Management of Non-Culprit Lesions in STEMI Patients with Multivessel Disease 90
Angiographic complexity of coronary artery disease according to syntax score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: A substudy of the bioscience trial 90
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial 90
No-Reflow Phenomenon: Pathophysiology, Diagnosis, Prevention, and Treatment. A Review of the Current Literature and Future Perspectives. 89
Reperfusion Correlates and Clinical Outcomes of Right Ventricular Dysfunction in Patients With Inferior ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention 89
Cangrelor, tirofiban, and chewed or standard prasugrel regimens in patients with st-segment-elevation myocardial infarction: Primary results of the FABOLUS-FASTER trial 89
Harnessing Multi-modality and Expert Knowledge for Adverse Events Prediction in Clinical Notes 88
Double Inversion Technique for Multivessel Primary PCI in Dextrocardia 86
Correction to: Acute advanced aortic stenosis 86
Effect of drug-eluting stents in patients with acute ST-segmentelevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis of randomised trials and an adjusted indirect comparison. 86
[SICI-GISE/SICOA Consensus document: Clinical follow-up of patients after acute coronary syndrome or percutaneous coronary intervention] 84
Antiplatelet theRapy after Genous EPC-capturing coroNary stenT implantatiOn: The ARGENTO Study: a prospective, multicenter registry. 84
Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials 84
New perspectives for transcatheter aortic valve implantation: more than a "simple" alternative to surgery. 84
[Debate on dual pathway inhibition: Antiplatelet therapy in patients with peripheral artery disease: old but gold?] 83
Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII study 83
Effects of Guiding Catheter Disengagement on Resting Indexes for the Assessment of Coronary Artery Stenoses 82
A Comparison Between Radial Artery Compression Devices for Patent Hemostasis After Transradial Percutaneous Interventions 82
A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study 81
From biodegradable polymers to bioresorbable vascular scaffolds: available evidence in the current era of new-generation DES 80
Venous Thromboembolism and Cancer: A Comprehensive Review from Pathophysiology to Novel Treatment 79
Sirolimus- versus paclitaxel-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials. 78
Long-term safety and efficacy of drug-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials. 78
Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients with Acute ST-Segment Elevation Myocardial Infarction: Insights from the 2-Year Follow-Up of the BIOSCIENCE Trial 78
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients 77
Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI 76
Is direct stenting superior to stenting with predilation inpatients treated with percutaneous coronary intervention? Results from a meta-analysis of 24 randomised controlled trials. 76
Early stent thrombosis with bivalirudin in patients undergoing percutaneous coronary intervention. A meta-analysis of randomised clinical trials 76
Mortality after Bleeding versus Myocardial Infarction in Coronary Artery Disease: A Systematic Review and Meta-Analysis 76
Acute advanced aortic stenosis 76
Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials. 75
Bleeding risk in patients undergoing percutaneous coronary intervention: how to define, identify and treat high-risk patients 74
Relationship between changes in platelet reactivity and ischemic?events following percutaneous coronary intervention: A?meta-regression analysis of 30 randomized trials 73
Effect of an invasive strategy on outcome in patients ≥75 years of age with non-St-elevation acute coronary syndrome 70
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction 69
Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak 68
Renal denervation and long-term results 67
What About Pharmacologic Therapy? 67
Coronary artery disease and myocardial revascularization in patients undergoing transcatheter aortic valve replacement 66
Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 66
Antithrombotic therapy and vascular access site: A choice not mutually exclusive 65
The ultimaster biodegradable-polymer sirolimus-eluting stent: An updated review of clinical evidence 65
Multi-slice computed tomography assessment of stent position in a patient with acute coronary syndrome and anomalous origin of the coronary arteries : online article - case report 64
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent for percutaneous coronary revascularization: 2-year results of the BIOSCIENCE trial 64
Predicting Recurrent Restenosis After Drug-eluting Balloon: A First Step Toward Personalized Treatment 64
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 64
Myocardial expression of FOXO3a-Atrogin-1 pathway in human heart failure. 63
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial 63
Use of the dual-antiplatelet therapy score to guide treatment duration after percutaneous coronary intervention 62
CardioPulse: Different bleeding scores and which one should we use? 62
Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes 61
A new approach to percutaneous coronary revascoularization in patient requiring undeferrable non-cardiac surgery. 61
Percutaneous Coronary Interventions for the Treatment of Stenoses in Small Coronary Arteries: A Network Meta-Analysis 61
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates 61
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry 59
Transcatheter Aortic Valve Replacement for the Treatment of Pure Native Aortic Valve Regurgitation: A Systematic Review 59
Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection 59
Unrestricted use of endeavour resolute stent in daily clinical practice: a single-centre prospective registry. 58
Totale 8.652
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 0 8 1 1 20 7 13 5
2021/2022491 4 1 8 1 1 21 2 19 89 6 62 277
2022/2023894 122 63 21 56 94 76 6 49 109 226 62 10
2023/2024683 22 128 114 36 26 25 15 89 19 26 116 67
2024/20254.095 190 212 16 41 107 157 506 252 394 420 1.417 383
2025/20265.343 880 740 839 973 1.461 450 0 0 0 0 0 0
Totale 12.126